Tag: Antidepressants
-

Antidepressants in Pregnancy: FDA Panel Debate and Lifeline
Overview: A Policy Debate Meets Real-World Need Media coverage has highlighted a tense moment as an FDA advisory panel scrutinized the safety of antidepressants used during pregnancy. The conversations, while focused on risk assessment, are ultimately about the daily realities faced by pregnant people and new mothers who struggle with depression or anxiety. Health professionals…
-

Antidepressants in Pregnancy: FDA Panel Questions vs Docs
FDA Panel Questions Antidepressants in Pregnancy In a recent session, members of an FDA advisory panel scrutinized the safety and necessity of using antidepressants during pregnancy. The discussions highlighted the ongoing tension between ensuring fetal safety and acknowledging the real-world needs of pregnant people who experience depression or anxiety. While some panelists raised concerns about…
-

Antidepressants in Pregnancy: FDA Panel Debate vs. Doctors’ Lifeline
FDA Panel Raises Questions About Antidepressants in Pregnancy In recent sessions, a panel of federal and medical experts scrutinized the use of antidepressants by pregnant individuals. The discussion centered on balancing potential risks to developing fetuses with the clear benefits these medications can offer to mothers suffering from depression and anxiety during pregnancy. While some…
-

Going off antidepressants? Expert tips for safe tapering
Considering stopping your antidepressant? If you’re thinking about stopping an antidepressant, you’re not alone. Many people reassess their treatment after months or years of use, guided by personal goals, side effects, or changes in life circumstances. The key is to approach the decision with care, under medical supervision, and a clear plan that prioritizes safety…
-

Going off an antidepressant safely: expert guidance on tapering and monitoring
Why people consider stopping antidepressants Deciding to stop antidepressant medication is a personal choice often influenced by symptom improvement, side effects, or a shift in life circumstances. Experts emphasize that there is no one-size-fits-all timeline. For some, symptoms stay well controlled after months or years of treatment; for others, ongoing symptoms may prompt a discussion…
-

Thinking about stopping antidepressants? Experts share safe ways to taper off
Why people consider stopping antidepressants Many people with depression or anxiety wonder if they’re ready to come off antidepressants after months or years of treatment. Some do so to reduce side effects, to feel more in control of their lives, or because they’ve been symptom-free for a sustained period. Yet deciding to taper off is…
-

New RACGP Guide Helps GPs Safely Deprescribe Antidepressants
Overview: A Step Toward Safer Antidepressant Deprescribing Depression and other mental health concerns are among the most common reasons patients visit general practice. As clinicians strive to provide effective treatment while minimizing harm, the Royal Australian College of General Practitioners (RACGP) has released a practical guide in its First do no harm series. This new…
-

New RACGP Guide Supports Safe Antidepressant Deprescribing in General Practice
Introduction: Addressing antidepressant deprescribing in primary care With mental health concerns one of the most common presentations in general practice, clinicians are increasingly navigating when and how to deprescribe antidepressants. The Royal Australian College of General Practitioners (RACGP) has released a new step-by-step guide as part of its First do no harm series to support…
-

New Guide to Support Safe Antidepressant Deprescribing in General Practice
Overview: A Practical Guide for Deprescribing Antidepressants With mental health concerns among the most common presentations in general practice, the Royal Australian College of General Practitioners (RACGP) has released a new step-by-step guide to support safe antidepressant deprescribing. This resource is part of the broader “First do no harm” initiative, which aims to help clinicians…

